Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Aug 10, 2010

Premium

Pacific Biosciences has appointed Terry Pizzie to be vice president of its Europe operations. Pizzie has worked at Genetix, now part of the Leica division at Danaher, as director of global commercial operations, and before that he was senior VP of commercial operations at Biacore, now part of GE Healthcare. Before those posts, Pizzie was VP, Europe, and VP of sales and marketing for Europe at Applied Biosystems.


Immucor has named Mason Morfit to its board of directors. Morfit is a partner with ValueAct Capital, an investment management firm. Prior to joining ValueAct Capital in 2001, he worked in equity research for Credit Suisse First Boston. Morfit is a director of Valeant Pharmaceuticals International and a former director of Advanced Medical Optics, Solexa, and MSD Performance.

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.